68 related articles for article (PubMed ID: 10522033)
1. Combined interferon, famciclovir and GM-CSF treatment of HBV infection in an individual with periarteritis nodosa.
Molloy PJ; Friedlander L; Van Thiel DH; Kania RJ
Hepatogastroenterology; 1999; 46(28):2529-31. PubMed ID: 10522033
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.
Kruger M; Böker KH; Zeidler H; Manns MP
J Hepatol; 1997 Apr; 26(4):935-9. PubMed ID: 9126810
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different treatment combinations for chronic hepatitis B infection.
Demirtürk N; Usluer G; Ozgünes I; Colak H; Kartal ED; Dinçer S
J Chemother; 2002 Jun; 14(3):285-9. PubMed ID: 12120884
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B.
Marques AR; Lau DT; McKenzie R; Straus SE; Hoofnagle JH
J Infect Dis; 1998 Nov; 178(5):1483-7. PubMed ID: 9780271
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.
Lau GK; Tsiang M; Hou J; Yuen S; Carman WF; Zhang L; Gibbs CS; Lam S
Hepatology; 2000 Aug; 32(2):394-9. PubMed ID: 10915748
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
[TBL] [Abstract][Full Text] [Related]
7. Famciclovir in chronic hepatitis B: results of a dose-finding study.
Trépo C; Jezek P; Atkinson G; Boon R; Young C
J Hepatol; 2000 Jun; 32(6):1011-8. PubMed ID: 10898322
[TBL] [Abstract][Full Text] [Related]
8. Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.
Nafa S; Ahmed S; Tavan D; Pichoud C; Berby F; Stuyver L; Johnson M; Merle P; Abidi H; Trépo C; Zoulim F
Hepatology; 2000 Nov; 32(5):1078-88. PubMed ID: 11050059
[TBL] [Abstract][Full Text] [Related]
9. [Dynamic changes of hepatitis B virus during treatment with lamivudine versus lamivudine plus famciclovir].
Hou J; Fen X; Nie Z
Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):81-3. PubMed ID: 10861109
[TBL] [Abstract][Full Text] [Related]
10. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.
Krüger M; Tillmann HL; Trautwein C; Bode U; Oldhafer K; Maschek H; Böker KH; Broelsch CE; Pichlmayr R; Manns MP
Liver Transpl Surg; 1996 Jul; 2(4):253-62. PubMed ID: 9346658
[TBL] [Abstract][Full Text] [Related]
11. Retransplantation for precore mutant-related chronic hepatitis B infection: prolonged survival in a patient receiving sequential ganciclovir/famciclovir therapy.
McCaughan G; Angus P; Bowden S; Shaw T; Breschkin A; Sheil R; Locarnini S
Liver Transpl Surg; 1996 Nov; 2(6):472-4. PubMed ID: 9346695
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor for the treatment of chronic hepatitis c.
Carreño V; Martín J; Pardo M; Brotons A; Anchía P; Navas S; Fernández M; Arocena C; Quiroga JA
Cytokine; 2000 Feb; 12(2):165-70. PubMed ID: 10671303
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
[TBL] [Abstract][Full Text] [Related]
14. [Drug therapy of chronic hepatitis B].
Renner EL; Lavanchy D
Soz Praventivmed; 1998; 43 Suppl 1():S21-3, S95-7. PubMed ID: 9833259
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B.
Martin J; Bosch O; Moraleda G; Bartolome J; Quiroga JA; Carreño V
Hepatology; 1993 Oct; 18(4):775-80. PubMed ID: 8406350
[TBL] [Abstract][Full Text] [Related]
16. In vivo effect of granulocyte-macrophage colony-stimulating factor and interferon combination on monocyte-macrophage and T-lymphocyte functions in chronic hepatitis B leukocytopenic patients.
Kountouras J; Boura P; Tsapas G
Hepatogastroenterology; 1998; 45(24):2295-302. PubMed ID: 9951912
[TBL] [Abstract][Full Text] [Related]
17. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
19. Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial.
Wedemeyer H; Böker KH; Pethig K; Petzold DR; Flemming P; Tillmann HL; Vollmar J; Bastürk M; Goldmann E; Griffin KE; Haverich A; Manns MP
Transplantation; 1999 Nov; 68(10):1503-11. PubMed ID: 10589947
[TBL] [Abstract][Full Text] [Related]
20. [Interferon therapy for chronic hepatitis B].
Kakumu S
Nihon Rinsho; 2004 Aug; 62 Suppl 8():315-20. PubMed ID: 15453337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
